Multiple physiological and metabolic targets

The term "Multiple physiological and metabolic targets" refers to a pharmacological profile where a drug or intervention exerts therapeutic effects by modulating several distinct biological pathways simultaneously. This is in contrast to the "one drug, one target" paradigm, as it involves the interaction with various receptors, enzymes, and signaling molecules to achieve a systemic outcome (Source: Nature Reviews Drug Discovery, doi:10.1038/nrd.2017.103). A prominent example is metformin, which targets mitochondrial complex I, activates the AMP-activated protein kinase (AMPK) pathway, and influences the gut microbiome to manage type 2 diabetes (Source: PubMed, PMID: 28848313). Because this designation encompasses a broad range of molecular entities rather than a single protein, it is classified as an incorrect or non-specific target in structured databases. Such multi-target approaches are often necessary for complex metabolic diseases where multiple physiological nodes are dysregulated. However, this complexity poses significant challenges in drug development, particularly in characterizing the precise mechanism of action and predicting potential off-target safety risks (Source: PubMed, PMID: 30571466).

Other names

Multi-target metabolic profilePleiotropic metabolic targets

Simultaneous modulation of diverse molecular pathways including AMPK activation, mitochondrial respiration, and hormonal signaling cascades to restore metabolic homeostasis.